Eli Lilly and (LLY)
Eli Lilly and Statistics
Share Statistics
Eli Lilly and has 947.99M shares outstanding. The number of shares has increased by -0.25% in one year.
| Shares Outstanding | 947.99M |
| Shares Change (YoY) | -0.25% |
| Shares Change (QoQ) | -0.14% |
| Owned by Institutions (%) | 86.14% |
| Shares Floating | 849.99M |
| Failed to Deliver (FTD) Shares | 13 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 7.02M, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 7.02M |
| Short % of Shares Out | 0.78% |
| Short % of Float | 0.88% |
| Short Ratio (days to cover) | 2.18 |
Valuation Ratios
The PE ratio is 65.43 and the forward PE ratio is 28.45. Eli Lilly and's PEG ratio is 0.64.
| PE Ratio | 65.43 |
| Forward PE | 28.45 |
| PS Ratio | 15.38 |
| Forward PS | 7.9 |
| PB Ratio | 48.38 |
| P/FCF Ratio | 1672.46 |
| PEG Ratio | 0.64 |
Enterprise Valuation
Eli Lilly and has an Enterprise Value (EV) of 723.28B.
| EV / Sales | 16.06 |
| EV / EBITDA | 47.5 |
| EV / EBIT | 82.02 |
| EV / FCF | 1745.78 |
Financial Position
The company has a current ratio of 0.12, with a Debt / Equity ratio of 2.35.
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | 2.35 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 81.21 |
| Interest Coverage | 28.91 |
Financial Efficiency
Return on Equity is 73.95% and Return on Invested Capital is 69.22%.
| Return on Equity | 73.95% |
| Return on Assets | 13.45% |
| Return on Invested Capital | 69.22% |
| Revenue Per Employee | $958.36K |
| Profits Per Employee | $225.32K |
| Employee Count | 47,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2.09B |
| Effective Tax Rate | 16.49% |
Stock Price Statistics
The stock price has increased by 12.8% in the last 52 weeks. The beta is 0.5, so Eli Lilly and's price volatility has been higher than the market average.
| Beta | 0.5 |
| 52-Week Price Change | 12.8% |
| 50-Day Moving Average | 835.66 |
| 200-Day Moving Average | 847.18 |
| Relative Strength Index (RSI) | 57.94 |
| Average Volume (20 Days) | 3.61M |
Income Statement
In the last 12 months, Eli Lilly and had revenue of 45.04B and earned 10.59B in profits. Earnings per share was 11.8.
| Revenue | 45.04B |
| Gross Profit | 36.62B |
| Operating Income | 17.5B |
| Net Income | 10.59B |
| EBITDA | 15.23B |
| EBIT | 13.46B |
| Earnings Per Share (EPS) | 11.8 |
Balance Sheet
The company has 3.27B in cash and 33.64B in debt, giving a net cash position of -30.38B.
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 33.64B |
| Net Cash | -30.38B |
| Retained Earnings | 0 |
| Total Assets | 78.71B |
| Working Capital | -24.86B |
Cash Flow
In the last 12 months, operating cash flow was 8.82B and capital expenditures -8.4B, giving a free cash flow of 414.3M.
| Operating Cash Flow | 8.82B |
| Capital Expenditures | -8.4B |
| Free Cash Flow | 414.3M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 81.31%, with operating and profit margins of 38.86% and 23.51%.
| Gross Margin | 81.31% |
| Operating Margin | 38.86% |
| Pretax Margin | 28.15% |
| Profit Margin | 23.51% |
| EBITDA Margin | 33.81% |
| EBIT Margin | 38.86% |
| FCF Margin | 0.92% |
Dividends & Yields
LLY pays an annual dividend of $6.7, which amounts to a dividend yield of 0.64%.
| Dividend Per Share | $6.70 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | 15.38% |
| Payout Ratio | 57.07% |
| Earnings Yield | 1.53% |
| FCF Yield | 0.06% |
Analyst Forecast
The average price target for LLY is $1008, which is 19.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $1008 |
| Price Target Difference | 19.8% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
Stock Splits
The last stock split was on Oct 16, 1997. It was a forward split with a ratio of 2:1.
| Last Split Date | Oct 16, 1997 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 7.24 |
| Piotroski F-Score | 6 |